Page last updated: 2024-08-16

ribavirin and Astrocytoma, Grade IV

ribavirin has been researched along with Astrocytoma, Grade IV in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Focosi, D; Halatsch, ME; Heiland, T; Hill, QA; Karpel-Massler, G; Kast, RE; Mellstedt, H; Wion, D1
Brem, H; Casaos, J; Choi, J; Eisinger-Mathason, TSK; Felder, R; Frikeche, J; Gorelick, N; Lott, T; Mangraviti, A; Scotland, SJ; Sesen, J; Skuli, N; Tyler, B; Volpin, F1
Cairncross, JG; Eisenhauer, E; Langleben, A; Macdonald, DR; Stewart, DJ1
Drabek, K; Medić-Mijacević, L; Pesić, M; Pietrzkowski, Z; Piperski, V; Rakić, L; Ruzdijić, S1
Ausserer, B; Chiba, P; Czermak, B; Gersdorf, E; Goebl, R; Knoflach, A; Murr, C; Pillwein, K; Schuchter, K; Stockhammer, G1

Reviews

1 review(s) available for ribavirin and Astrocytoma, Grade IV

ArticleYear
Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:5

    Topics: Bone Marrow Cells; Brain; Cell Proliferation; Dapsone; Fenofibrate; Glioblastoma; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppression Therapy; Ribavirin

2017

Trials

1 trial(s) available for ribavirin and Astrocytoma, Grade IV

ArticleYear
Phase II study of tiazofurin in gliomas in adults. A National Cancer Institute of Canada study.
    Journal of neuro-oncology, 1993, Volume: 15, Issue:2

    Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Ribavirin

1993

Other Studies

3 other study(ies) available for ribavirin and Astrocytoma, Grade IV

ArticleYear
Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Oncogene, 2017, 05-25, Volume: 36, Issue:21

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Repositioning; Female; Glioblastoma; Humans; Mice; Mice, Nude; Rats; Rats, Inbred F344; Ribavirin; Temozolomide; Xenograft Model Antitumor Assays

2017
8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells.
    Anti-cancer drugs, 2000, Volume: 11, Issue:9

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Agents; Cell Differentiation; Cell Division; Endothelial Growth Factors; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Lymphokines; Ribavirin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000
Purine metabolism of human glioblastoma in vivo.
    Cancer research, 1990, Mar-01, Volume: 50, Issue:5

    Topics: Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Purine Nucleosides; Purine Nucleotides; Ribavirin

1990